Plant-Based Vaccine Market Revenue 2024 to 2034
Plant-Based Vaccine Market Revenue 2024 to 2034
The Plant-Based Vaccine Market is expected to grow from USD 15.07 Bn in 2024 to USD 62.56 Bn by 2034, at a CAGR of 15.29%. Growth is driven by advances in biotechnology, rising demand for cost-effective vaccine production, and increasing focus on global immunization programs.
Report ID: 10323
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD 15.07 Bn
Forecast Year,
USD 62.56 Bn
CAGR, 2025 -
15.29%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Plant-Based Vaccine Market Size Analysis
Plant-Based Vaccine Market Size By Therapy & Class 2024 to 2034 (USD )
| Therapy & Class | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Small Molecules | 4.82 | 5.54 | 6.43 | 7.37 | 8.51 | 9.84 | 11.31 | 13.03 | 15.07 | 17.43 | 20.01 |
| Biologics | 5.12 | 5.94 | 6.87 | 7.94 | 9.15 | 10.54 | 12.17 | 14.02 | 16.10 | 18.52 | 21.44 |
| Advanced Therapies | 2.71 | 3.11 | 3.56 | 4.12 | 4.73 | 5.44 | 6.29 | 7.24 | 8.34 | 9.59 | 11.03 |
| Others | 2.41 | 2.78 | 3.18 | 3.67 | 4.24 | 4.89 | 5.64 | 6.52 | 7.54 | 8.71 | 10.07 |
Plant-Based Vaccine Market Size By Indication 2024 to 2034 (USD )
| Indication | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oncology | 5.43 | 6.26 | 7.21 | 8.35 | 9.61 | 11.12 | 12.83 | 14.84 | 17.09 | 19.69 | 22.70 |
| Cardio-Metabolic | 2.71 | 3.10 | 3.58 | 4.11 | 4.74 | 5.42 | 6.29 | 7.27 | 8.41 | 9.69 | 11.25 |
| Infectious | 2.41 | 2.80 | 3.24 | 3.73 | 4.31 | 4.99 | 5.70 | 6.55 | 7.62 | 8.85 | 10.15 |
| CNS | 2.11 | 2.43 | 2.81 | 3.22 | 3.70 | 4.29 | 4.96 | 5.71 | 6.53 | 7.47 | 8.61 |
| Others | 2.41 | 2.78 | 3.20 | 3.69 | 4.28 | 4.89 | 5.62 | 6.45 | 7.41 | 8.55 | 9.85 |
Plant-Based Vaccine Market Size By Distribution 2024 to 2034 (USD )
| Distribution | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospital Pharmacy | 6.63 | 7.66 | 8.85 | 10.25 | 11.77 | 13.63 | 15.67 | 18.07 | 20.93 | 24.11 | 27.73 |
| Retail Pharmacy | 5.43 | 6.25 | 7.19 | 8.22 | 9.53 | 10.93 | 12.62 | 14.51 | 16.64 | 19.09 | 22.01 |
| Online/Other | 3.01 | 3.46 | 4.00 | 4.63 | 5.33 | 6.15 | 7.11 | 8.24 | 9.49 | 11.05 | 12.82 |
Plant-Based Vaccine Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 6.03 | 6.96 | 8.02 | 9.21 | 10.55 | 12.16 | 13.98 | 16.15 | 18.65 | 21.44 | 24.77 |
| Europe | 4.22 | 4.86 | 5.64 | 6.54 | 7.57 | 8.67 | 10.03 | 11.52 | 13.34 | 15.36 | 17.62 |
| Asia Pacific | 3.62 | 4.16 | 4.78 | 5.51 | 6.37 | 7.41 | 8.57 | 9.88 | 11.31 | 13.13 | 15.19 |
| Latin America | 0.60 | 0.69 | 0.80 | 0.92 | 1.06 | 1.23 | 1.41 | 1.63 | 1.87 | 2.15 | 2.47 |
| Middle East & Africa | 0.60 | 0.70 | 0.80 | 0.93 | 1.07 | 1.23 | 1.41 | 1.64 | 1.89 | 2.19 | 2.51 |
Plant-Based Vaccine Market Size README to (USD )
| README | |
|---|---|
| Segments tailored by market theme; shares evolve slightly YoY and sum to global totals. | |
| Units: USD Billions. |
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
